This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/uk/535168-covid-antibody-drug-trump/
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
| Version 0 | Version 1 |
|---|---|
| Antibody cocktail, touted by Trump as 'cure' for Covid-19, to be launched across UK next week for coronavirus patients | Antibody cocktail, touted by Trump as 'cure' for Covid-19, to be launched across UK next week for coronavirus patients |
| (about 1 month later) | |
| A new antibody drug, Ronapreve, will become available for coronavirus parents across Britain next week, the UK government has said. The drug was used to treat then-US President Donald Trump, who hailed it as a "cure" for Covid-19. | A new antibody drug, Ronapreve, will become available for coronavirus parents across Britain next week, the UK government has said. The drug was used to treat then-US President Donald Trump, who hailed it as a "cure" for Covid-19. |
| The drug, jointly developed by Roche and Regeneron, will be initially used among those with a weak antibody response to the virus, British health authorities said Friday. | The drug, jointly developed by Roche and Regeneron, will be initially used among those with a weak antibody response to the virus, British health authorities said Friday. |
| "We have secured a brand new treatment for our most vulnerable patients in hospitals across the UK and I am thrilled it will be saving lives from as early as next week," Health Secretary Sajid Javid said in a statement announcing the Ronapreve launch. | "We have secured a brand new treatment for our most vulnerable patients in hospitals across the UK and I am thrilled it will be saving lives from as early as next week," Health Secretary Sajid Javid said in a statement announcing the Ronapreve launch. |
| Eligibility for the treatment will be determined via antibody testing, with those showing a lack of "adequate existing antibody response" approved to receive the drug, Javid added. Ronapreve was greenlit for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) back in August. | Eligibility for the treatment will be determined via antibody testing, with those showing a lack of "adequate existing antibody response" approved to receive the drug, Javid added. Ronapreve was greenlit for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) back in August. |
| Hailing the upcoming rollout, one of the companies behind the drug expressed hope for the continuation of its partnership with British health authorities. | Hailing the upcoming rollout, one of the companies behind the drug expressed hope for the continuation of its partnership with British health authorities. |
| "This is just another step in our journey to overcome Covid-19, and we will continue to collaborate with partners to identify and investigate multiple options that may help different groups of patients," Covid-19 Lead at Roche, Paul McManus, said in a statement. | "This is just another step in our journey to overcome Covid-19, and we will continue to collaborate with partners to identify and investigate multiple options that may help different groups of patients," Covid-19 Lead at Roche, Paul McManus, said in a statement. |
| The drug is a monoclonal antibody combination treatment. Ronapreve is administered through injections or infusions, binding with the coronavirus and stopping the disease from reaching cells in the respiratory system – effectively, it is said to act similarly to a natural immune response. | The drug is a monoclonal antibody combination treatment. Ronapreve is administered through injections or infusions, binding with the coronavirus and stopping the disease from reaching cells in the respiratory system – effectively, it is said to act similarly to a natural immune response. |
| The drug garnered worldwide attention when former US President Donald Trump caught Covid-19 during his time in office and was offered the experimental treatment. According to Trump, the drug demonstrated high efficacy, with the then-president hailing it as an ultimate "cure" for coronavirus. | The drug garnered worldwide attention when former US President Donald Trump caught Covid-19 during his time in office and was offered the experimental treatment. According to Trump, the drug demonstrated high efficacy, with the then-president hailing it as an ultimate "cure" for coronavirus. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
Previous version
1
Next version